PubMed:18816083 / 1143-1297 JSONTXT

{"project":"GlyCosmos600-CLO","denotations":[{"id":"T9","span":{"begin":34,"end":39},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"In addition, pretreatment of KB/V cells with a CyPA-binding immunosuppressive drug, cyclosporine A (CsA), enhanced their chemosensitivity to VCR and 5-Fu."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T9","span":{"begin":0,"end":154},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":154},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In addition, pretreatment of KB/V cells with a CyPA-binding immunosuppressive drug, cyclosporine A (CsA), enhanced their chemosensitivity to VCR and 5-Fu."}

{"project":"GlyCosmos600-FMA","denotations":[{"id":"T14","span":{"begin":34,"end":39},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"In addition, pretreatment of KB/V cells with a CyPA-binding immunosuppressive drug, cyclosporine A (CsA), enhanced their chemosensitivity to VCR and 5-Fu."}

{"project":"pubmed-enju-pas","denotations":[{"id":"EnjuParser_T181","span":{"begin":0,"end":2},"obj":"IN"},{"id":"EnjuParser_T182","span":{"begin":3,"end":11},"obj":"NN"},{"id":"EnjuParser_T183","span":{"begin":11,"end":12},"obj":"-COMMA-"},{"id":"EnjuParser_T184","span":{"begin":13,"end":25},"obj":"NN"},{"id":"EnjuParser_T185","span":{"begin":26,"end":28},"obj":"IN"},{"id":"EnjuParser_T186","span":{"begin":29,"end":33},"obj":"NN"},{"id":"EnjuParser_T187","span":{"begin":34,"end":39},"obj":"NNS"},{"id":"EnjuParser_T188","span":{"begin":40,"end":44},"obj":"IN"},{"id":"EnjuParser_T189","span":{"begin":45,"end":46},"obj":"DT"},{"id":"EnjuParser_T190","span":{"begin":47,"end":59},"obj":"JJ"},{"id":"EnjuParser_T191","span":{"begin":60,"end":77},"obj":"JJ"},{"id":"EnjuParser_T192","span":{"begin":78,"end":82},"obj":"NN"},{"id":"EnjuParser_T193","span":{"begin":82,"end":83},"obj":"-COMMA-"},{"id":"EnjuParser_T194","span":{"begin":84,"end":96},"obj":"NN"},{"id":"EnjuParser_T195","span":{"begin":97,"end":98},"obj":"NN"},{"id":"EnjuParser_T196","span":{"begin":99,"end":100},"obj":"-LRB-"},{"id":"EnjuParser_T197","span":{"begin":100,"end":103},"obj":"NN"},{"id":"EnjuParser_T198","span":{"begin":103,"end":104},"obj":"-RRB-"},{"id":"EnjuParser_T199","span":{"begin":104,"end":105},"obj":"-COMMA-"},{"id":"EnjuParser_T200","span":{"begin":106,"end":114},"obj":"VBD"},{"id":"EnjuParser_T201","span":{"begin":115,"end":120},"obj":"PRP-DOLLAR-"},{"id":"EnjuParser_T202","span":{"begin":121,"end":137},"obj":"NN"},{"id":"EnjuParser_T203","span":{"begin":138,"end":140},"obj":"TO"},{"id":"EnjuParser_T204","span":{"begin":141,"end":144},"obj":"NNP"},{"id":"EnjuParser_T205","span":{"begin":145,"end":148},"obj":"CC"},{"id":"EnjuParser_T206","span":{"begin":149,"end":154},"obj":"NN"}],"relations":[{"id":"EnjuParser_R181","pred":"arg1Of","subj":"EnjuParser_T205","obj":"EnjuParser_T181"},{"id":"EnjuParser_R182","pred":"arg2Of","subj":"EnjuParser_T182","obj":"EnjuParser_T181"},{"id":"EnjuParser_R183","pred":"arg1Of","subj":"EnjuParser_T205","obj":"EnjuParser_T183"},{"id":"EnjuParser_R184","pred":"arg1Of","subj":"EnjuParser_T184","obj":"EnjuParser_T185"},{"id":"EnjuParser_R185","pred":"arg2Of","subj":"EnjuParser_T187","obj":"EnjuParser_T185"},{"id":"EnjuParser_R186","pred":"arg1Of","subj":"EnjuParser_T187","obj":"EnjuParser_T186"},{"id":"EnjuParser_R187","pred":"arg1Of","subj":"EnjuParser_T184","obj":"EnjuParser_T188"},{"id":"EnjuParser_R188","pred":"arg2Of","subj":"EnjuParser_T192","obj":"EnjuParser_T188"},{"id":"EnjuParser_R189","pred":"arg1Of","subj":"EnjuParser_T192","obj":"EnjuParser_T189"},{"id":"EnjuParser_R190","pred":"arg1Of","subj":"EnjuParser_T192","obj":"EnjuParser_T190"},{"id":"EnjuParser_R191","pred":"arg1Of","subj":"EnjuParser_T192","obj":"EnjuParser_T191"},{"id":"EnjuParser_R192","pred":"arg1Of","subj":"EnjuParser_T192","obj":"EnjuParser_T193"},{"id":"EnjuParser_R193","pred":"arg2Of","subj":"EnjuParser_T195","obj":"EnjuParser_T193"},{"id":"EnjuParser_R194","pred":"arg1Of","subj":"EnjuParser_T195","obj":"EnjuParser_T194"},{"id":"EnjuParser_R195","pred":"arg1Of","subj":"EnjuParser_T195","obj":"EnjuParser_T196"},{"id":"EnjuParser_R196","pred":"arg2Of","subj":"EnjuParser_T197","obj":"EnjuParser_T196"},{"id":"EnjuParser_R197","pred":"arg3Of","subj":"EnjuParser_T198","obj":"EnjuParser_T196"},{"id":"EnjuParser_R198","pred":"arg1Of","subj":"EnjuParser_T200","obj":"EnjuParser_T199"},{"id":"EnjuParser_R199","pred":"arg1Of","subj":"EnjuParser_T184","obj":"EnjuParser_T200"},{"id":"EnjuParser_R200","pred":"arg2Of","subj":"EnjuParser_T202","obj":"EnjuParser_T200"},{"id":"EnjuParser_R201","pred":"arg1Of","subj":"EnjuParser_T202","obj":"EnjuParser_T201"},{"id":"EnjuParser_R202","pred":"arg1Of","subj":"EnjuParser_T202","obj":"EnjuParser_T203"},{"id":"EnjuParser_R203","pred":"arg2Of","subj":"EnjuParser_T204","obj":"EnjuParser_T203"},{"id":"EnjuParser_R204","pred":"arg1Of","subj":"EnjuParser_T200","obj":"EnjuParser_T205"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"In addition, pretreatment of KB/V cells with a CyPA-binding immunosuppressive drug, cyclosporine A (CsA), enhanced their chemosensitivity to VCR and 5-Fu."}